Infectious disease animal models serve as invaluable tools for comprehending disease pathogenesis, assessing therapeutic interventions, and advancing medical understanding. At our company, we are deeply committed to the development of top-notch animal models and have made substantial contributions to this field. Entering a partnership with us, you will receive top assistance making it easier for you to conduct your infectious diseases study and get to commercialization faster.
Overview of Animal Models for Infectious Disease
An infectious disease animal model is defined as any organism other than a human which helps in the study of infectious diseases in people. Animals are utilized in clinical studies as a model they are bred to mimic features seen in patients including but not limited to, symptoms, and reactions to various forms of treatment. With the aid of animal models, researchers are in a position to control variables which would help in understanding the progression of a disease while assessing treatment measures.
Pathogen-host Interaction Research
These models enable scientists to study the intricate dynamics between the pathogen and the host’s immune system offering great understanding on the development of a disease and how the immune system reacts to it. Drug targets and treatment development strategies can be established through these models.
Evaluation of Potential Therapies
These models enable the assessment of a new treatment's safety and efficacy before its use in people. This evaluation ensures that only reasonable and safer interventions are put forward for human clinical trials. In turn, this reduces the risk to human subjects and improves the effectiveness of medicine and health care.
Market Size of Infectious Disease Animal Models
In recent years, the growing pattern of infectious diseases has brought a necessity for competent cures and an urge for precision medicine. Consequently, the market of infectious disease animal model has grown by leaps and bounds. Reports say that the animal model market globally was worth more than $2.48 billion in 2023 and is expected to attain around $5.72 billion by 2033. The compound annual growth rate (CAGR) for the years 2024-2033 is expected to be around 8.71%. Among them, the infectious disease animal model market accounts for a large share.
Fig. 1 Animal models of mpox virus infection and disease. (Wei Z K, et al., 2023)
Our Services
Appreciating the importance of animal models, in enhancing the area of infectious disease, our company focuses on providing high quality animal models which allow us to study the complex mechanisms of infectious diseases and how they could be treated. By engaging various animal species, infecting them with appropriate pathogens and tracing the disease, we dedicate ourselves to resource superiority in a bid to advance the scientists in their quest of comprehending, controlling and curing infectious diseases.
Types of Infectious Disease Animal Models
We have a considerable knowledge and expertise in picking and applying animal models that have pathogens. We pay special attention to the choice of a pathogen that is very closely related to the one affecting human beings in order to ensure that the disease symptoms and its progression is accurately replicated.
We provide models that truly reflect an illness in a human based on specific changes in genes. This enables us to change the genome of an animal and create various manifestations of a disease, thereby assisting in the investigation of genetic pathways as well as the mechanisms of treatment.
Our focus is on developing humanized animal models that mimic human immunology and physiology. The incorporation of human immune cells, tissues or organs into animal models allows us to connect the preclinical stage of research with clinical trials.
Application of Infectious Disease Animal Models
Our company develops animal models for a variety of infectious diseases, including bacterial infections, viral infections, parasitic infections, fungal infections, and prion diseases. With the aid of these models, we are able to help you undertake preclinical testing of therapeutics for infectious diseases such as pharmacokinetic and pharmacodynamic studies, drug safety evaluation, and many other tasks.
If you are interested in our services, please feel free to contact us for more details and quotation information of related services.
References
- Wei Z K, Zhao Y C, Wang Z D, et al. Animal models of mpox virus infection and disease[J]. Infectious Medicine, 2023, 2(3): 153-166.
- Swearengen J R. Choosing the right animal model for infectious disease research[J]. Animal models and experimental medicine, 2018, 1(2): 100-108.
All of our services and products are intended for preclinical research use
only and cannot be used to diagnose, treat or manage patients.
